Dupixent Market: Strategic Label Expansions Strengthen Market Position in Multiple Chronic Inflammatory Conditions
Market Overview The Dupixent Market has emerged as a significant segment within the global biologics and immunotherapy landscape, driven by the growing prevalence of chronic inflammatory diseases. Dupixent, a monoclonal antibody developed using advanced recombinant DNA and antibody engineering technologies, has transformed the treatment paradigm for conditions such as atopic...
0 Comments 0 Shares 141 Views 0 Reviews
Sponsored